Women who survive cancer are more likely to experience cancer-related fatigue and depression than men, according to new ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

We are navigating political interference, institutional instability, and growing uncertainty across the cancer research ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

The session follows the American Association for Cancer Research's prior call to action against executive orders that would ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery, today ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Ending a 20-year-plus drought, Merck & Co.’s Keytruda demonstrated that its use around surgery can reduce the risk of certain ...

Findings demonstrate ATYR2810's anti-tumor activity and increased survival in a model of glioblastoma multiforme (GBM), a primary form of brain cancer.

Prior studies have shown that women may absorb cancer therapies differently than men, but this study focused on the fallout ...

New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...